Cold & Cough Remedies (Pharmacies) - Tanzania

Revenue in the Cold & Cough Remedies market is projected to reach US$71.80m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 10.22%, resulting in a market volume of US$116.80m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$1.03 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Tanzania has been experiencing significant growth in recent years.

Customer preferences: Customers in Tanzania have shown a growing preference for over-the-counter cold and cough remedies purchased from pharmacies. This can be attributed to several factors. Firstly, the convenience of purchasing these remedies from pharmacies allows customers to quickly and easily access the products they need. Additionally, the trust placed in pharmacies as reliable sources of medication has also contributed to the preference for purchasing cold and cough remedies from these establishments.

Trends in the market: One major trend in the Cold & Cough Remedies (Pharmacies) market in Tanzania is the increasing demand for natural and herbal remedies. Customers are becoming more health-conscious and are seeking alternatives to traditional pharmaceutical products. This trend is driven by a desire for more natural and holistic approaches to healthcare. As a result, pharmacies in Tanzania are expanding their product offerings to include a wider range of natural and herbal cold and cough remedies. Another trend in the market is the growing popularity of combination products. Customers are increasingly seeking remedies that address multiple symptoms at once, such as cold and cough syrups that also provide relief from congestion or sore throat. This trend is driven by the desire for convenience and efficiency in managing cold and cough symptoms. Pharmacies in Tanzania are responding to this trend by stocking a variety of combination products to meet customer demand.

Local special circumstances: One local special circumstance that has influenced the Cold & Cough Remedies (Pharmacies) market in Tanzania is the prevalence of respiratory infections. Tanzania has a high burden of respiratory infections, including pneumonia and tuberculosis. These infections often result in cold and cough symptoms, leading to a high demand for remedies to alleviate these symptoms. The need to address respiratory infections has contributed to the growth of the market for cold and cough remedies in Tanzania.

Underlying macroeconomic factors: Several macroeconomic factors have contributed to the development of the Cold & Cough Remedies (Pharmacies) market in Tanzania. Firstly, the country has experienced steady economic growth in recent years, leading to an increase in disposable income. As a result, customers have more purchasing power and are able to afford cold and cough remedies from pharmacies. Additionally, the expanding healthcare infrastructure in Tanzania has played a role in the growth of the market. The government has made efforts to improve access to healthcare services, including the establishment of more pharmacies in rural areas. This has increased the availability of cold and cough remedies, leading to higher sales in the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Tanzania is experiencing growth due to customer preferences for convenience and trust in pharmacies, as well as the trends towards natural and combination remedies. The high burden of respiratory infections and the macroeconomic factors of economic growth and improved healthcare infrastructure have also contributed to the development of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.